[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 36 of about 36
1. Jakowski JD, Wakely PE Jr: Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Cancer; 2007 Oct 25;111(5):298-305
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases.
  • BACKGROUND: Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft-tissue sarcoma rarely subjected to cytologic analysis.
  • METHODS: The cytology files were reviewed for all soft-tissue lesions signed out as chondrosarcoma, myxoid sarcoma, and EMC, and the tissue files for any cases of EMC that had corresponding cytopathology.
  • Five cases were correctly and categorically diagnosed by the cytologic method as EMC, 1 as chondrosarcoma favor EMC, 1 as sarcoma favor EMC, and 1 as myxoid spindle/epithelial neoplasm.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cytodiagnosis. Female. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17676582.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Oh BG, Han YH, Lee BH, Kim SY, Hwang YJ, Seo JW, Kim YH, Cha SJ, Hur G, Joo M: Primary extraskeletal mesenchymal chondrosarcoma arising from the pancreas. Korean J Radiol; 2007 Nov-Dec;8(6):541-4
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary extraskeletal mesenchymal chondrosarcoma arising from the pancreas.
  • We report here on a case of primary extraskeletal mesenchymal chondrosarcoma that arose from the pancreas.
  • Following excision of the mass, it was pathologically confirmed to be primary extraskeletal mesenchymal chondrosarcoma that arose from the pancreas.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Abdominal Pain / etiology. Adult. Contrast Media / administration & dosage. Diagnosis, Differential. Humans. Iohexol / analogs & derivatives. Male. Necrosis. Pancreas / pathology. Pancreas / radiography. Portal Vein / radiography. Radiographic Image Enhancement / methods. Rare Diseases. Retroperitoneal Space / radiography. Splenic Vein / radiography. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Imaging. 2003 May-Jun;27(3):187-90 [12727057.001]
  • [Cites] J Clin Oncol. 1985 Jun;3(6):858-63 [2409241.001]
  • [Cites] Cancer. 1986 Jun 15;57(12):2444-53 [3697943.001]
  • [Cites] Acta Cytol. 1990 Jul-Aug;34(4):529-32 [2375221.001]
  • [Cites] Cancer. 1959 Nov-Dec;12:1142-57 [14416919.001]
  • [Cites] Radiology. 1993 Mar;186(3):819-26 [8430193.001]
  • [Cites] Acta Cytol. 1995 Nov-Dec;39(6):1237-43 [7484001.001]
  • [Cites] Radiat Med. 1999 May-Jun;17(3):239-41 [10440114.001]
  • [Cites] J Bone Joint Surg Am. 1964 Jun;46:747-54 [14161087.001]
  • [Cites] Acta Obstet Gynecol Scand. 1989;68(5):467-8 [2520797.001]
  • (PMID = 18071285.001).
  • [ISSN] 1229-6929
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Contrast Media; 4419T9MX03 / Iohexol; 712BAC33MZ / iopromide
  • [Other-IDs] NLM/ PMC2627457
  •  go-up   go-down


3. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Dal Cin P, Araujo DM, Lev DC, López-Terrada D, Lazar AJ: Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol; 2008 Nov;21(11):1303-10
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
  • Extraskeletal myxoid chondrosarcoma is a rare soft tissue tumor characterized by a nodular growth pattern with eosinophilic cells usually in a reticular pattern and abundant myxoid stroma.
  • In contrast to other myxoid sarcomas, the majority of extraskeletal myxoid chondrosarcomas harbor a balanced translocation, t(9;22)(q22;q12), that fuses EWSR1 with NR4A3 (also known as CHN).
  • We examined the diagnostic utility of fluorescence in situ hybridization for extraskeletal myxoid chondrosarcoma using the LSI EWSR1 break-apart probe (Abbott Molecular/Vysis, Des Plaines, IL, USA).
  • Sixteen cases of extraskeletal myxoid chondrosarcoma with formalin-fixed paraffin-embedded tissue available were retrieved (1991-2007).
  • In this study, the vast majority of extraskeletal myxoid chondrosarcomas are associated with a rearrangement at the EWSR1 locus (22q12).
  • Fluorescence in situ hybridization is useful to support the diagnosis of extraskeletal myxoid chondrosarcomas and may help to differentiate it from mimics such as other myxoid sarcomas, particularly in limited biopsies.
  • [MeSH-major] Calmodulin-Binding Proteins / genetics. Chondrosarcoma / diagnosis. RNA-Binding Proteins / genetics. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Chromosomes, Human, Pair 22. Chromosomes, Human, Pair 9. DNA, Neoplasm / genetics. Diagnosis, Differential. Extremities. Female. Gene Rearrangement. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Sarcoma / diagnosis. Translocation, Genetic

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18587326.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calmodulin-Binding Proteins; 0 / DNA, Neoplasm; 0 / EWSR1 protein, human; 0 / RNA-Binding Proteins
  •  go-up   go-down


Advertisement
4. Heyse TJ, Malcherczyk D, Moll R, Timmesfeld N, Wapelhorst J, Fuchs-Winkelmann S, Paletta JR, Schofer MD: CD44: survival and metastasis in chondrosarcoma. Osteoarthritis Cartilage; 2010 Jun;18(6):849-56
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD44: survival and metastasis in chondrosarcoma.
  • OBJECTIVE: Recent studies have shown abnormal expression of CD44s and some of its isoforms in many human malignancies, but little is known about the presence of CD44 in chondrosarcoma.
  • METHOD: Thirty paraffin-embedded chondrosarcoma samples were immunostained with monoclonal antibodies for CD44s, CD44v5 and CD44v6.
  • RESULTS: Among the 30 patients (median age 50 years) there were 22 conventional chondrosarcomas, two dedifferentiated chondrosarcomas, two extraskeletal chondrosarcomas, and one periostal, mesenchymal, clear cell and myxoid chondrosarcoma each.
  • CONCLUSIONS: Overexpression of CD44s correlated significantly with metastatic potential and with poorer survival in patients with chondrosarcoma.

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20171296.001).
  • [ISSN] 1522-9653
  • [Journal-full-title] Osteoarthritis and cartilage
  • [ISO-abbreviation] Osteoarthr. Cartil.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Protein Isoforms
  •  go-up   go-down


5. Drilon AD, Popat S, Bhuchar G, D'Adamo DR, Keohan ML, Fisher C, Antonescu CR, Singer S, Brennan MF, Judson I, Maki RG: Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer; 2008 Dec 15;113(12):3364-71
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy.
  • BACKGROUND: Extraskeletal myxoid chondrosarcoma (EMC) is a genetically distinct sarcoma with a propensity for local recurrence and metastasis despite an indolent course.
  • [MeSH-major] Chondrosarcoma / drug therapy. Chondrosarcoma / surgery. Soft Tissue Neoplasms / drug therapy. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Disease-Free Survival. Female. Humans. Male. Middle Aged. Retrospective Studies. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virchows Arch. 1999 Nov;435(5):524-30 [10592057.001]
  • [Cites] Biochem J. 2007 Jun 1;404(2):197-206 [17302560.001]
  • [Cites] Adv Anat Pathol. 2000 Mar;7(2):73-8 [10721413.001]
  • [Cites] Mod Pathol. 2000 Aug;13(8):900-8 [10955458.001]
  • [Cites] Clin Orthop Relat Res. 2001 Jan;(382):185-90 [11153986.001]
  • [Cites] Cancer Res. 2000 Dec 15;60(24):6832-5 [11156374.001]
  • [Cites] Clin Cancer Res. 2001 Jul;7(7):2076-84 [11448926.001]
  • [Cites] Hum Pathol. 2001 Oct;32(10):1116-24 [11679947.001]
  • [Cites] Histopathology. 2001 Nov;39(5):514-24 [11737310.001]
  • [Cites] J Biol Chem. 2002 Jan 4;277(1):535-43 [11673470.001]
  • [Cites] Cancer Lett. 2002 Sep 8;183(1):87-94 [12049818.001]
  • [Cites] Genes Chromosomes Cancer. 2002 Dec;35(4):340-52 [12378528.001]
  • [Cites] Cancer. 2003 Mar 1;97(5):1285-92 [12599237.001]
  • [Cites] Bioorg Med Chem Lett. 2003 May 19;13(10):1801-4 [12729668.001]
  • [Cites] Mod Pathol. 2003 May;16(5):453-9 [12748252.001]
  • [Cites] Cytogenet Genome Res. 2002;98(4):245-8 [12826747.001]
  • [Cites] Clin Orthop Relat Res. 2003 Oct;(415):4-18 [14612624.001]
  • [Cites] Mod Pathol. 2004 Feb;17(2):214-21 [14657948.001]
  • [Cites] Curr Opin Oncol. 2004 Jul;16(4):342-54 [15187889.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Aug;40(4):325-8 [15188455.001]
  • [Cites] Exp Cell Res. 2004 Jul 15;297(2):585-92 [15212958.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Jul 15;152(2):101-7 [15262426.001]
  • [Cites] Acta Pathol Jpn. 1981 May;31(3):439-47 [7270148.001]
  • [Cites] Cancer. 1992 Dec 15;70(12):2827-30 [1451062.001]
  • [Cites] Am J Clin Oncol. 1995 Apr;18(2):161-3 [7900708.001]
  • [Cites] Cancer Genet Cytogenet. 1995 May;81(1):33-7 [7773957.001]
  • [Cites] Chest. 1995 Jul;108(1):281-2 [7606973.001]
  • [Cites] Int J Cancer. 1995 Aug 9;62(4):398-402 [7635565.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):350-62 [8996162.001]
  • [Cites] Oncogene. 1999 May 27;18(21):3303-8 [10359536.001]
  • [Cites] Am J Surg Pathol. 1999 Jun;23(6):636-50 [10366145.001]
  • [Cites] J Biol Chem. 2005 Jan 14;280(2):1199-208 [15536069.001]
  • [Cites] Pathol Int. 2005 Aug;55(8):453-63 [15998372.001]
  • [Cites] J Pathol. 2005 Aug;206(4):433-44 [15920699.001]
  • [Cites] Biol Pharm Bull. 2005 Sep;28(9):1603-7 [16141523.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jul 21;346(1):306-13 [16756948.001]
  • [Cites] Oncogene. 1999 Dec 9;18(52):7599-601 [10602520.001]
  • (PMID = 18951519.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA047179; United States / NCI NIH HHS / CA / P01 CA047179-15A2; United States / NCI NIH HHS / CA / P01 CA047179-18; United States / NCI NIH HHS / CA / P01-CA47179
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS139129; NLM/ PMC2779719
  •  go-up   go-down


6. Sangoi AR, Dulai MS, Beck AH, Brat DJ, Vogel H: Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation. Am J Surg Pathol; 2009 May;33(5):669-81
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, immunohistochemical staining was performed with antibodies against D2-40, S100, pankeratin, epithelial membrane antigen (EMA), brachyury, and glial fibrillary acidic protein (GFAP) in 4 cases of chordoid glioma, 6 skeletal myxoid chondrosarcomas, 10 chordoid meningiomas, 16 extraskeletal myxoid chondrosarcoma, 18 chordomas, 22 low-grade chondrosarcomas, and 27 enchondromas.
  • Staining with S100 demonstrated diffuse, strong positivity in all (100%) chordoid gliomas, skeletal myxoid chondrosarcomas, low-grade chondrosarcomas, and enchondromas, 94% of chordomas, and 81% of extraskeletal myxoid chondrosarcomas, with focal, moderate staining in 40% of chordoid meningiomas.
  • Pankeratin highlighted 100% of chordoid gliomas and chordomas, 38% of extraskeletal myxoid chondrosarcomas, and 20% of chordoid meningiomas.
  • EMA staining was positive in 100% of chordoid gliomas, 94% of chordomas, 90% of chordoid meningiomas, and 25% of extraskeletal myxoid chondrosarcomas.
  • EMA was the most effective antibody for differentiating chordoid meningioma from skeletal myxoid chondrosarcoma, low-grade chondrosarcoma, and enchondroma, whereas D2-40 was the most effective antibody for differentiating chordoid meningioma from extraskeletal myxoid chondrosarcoma and chordoma.
  • Our findings demonstrate that in conjunction with clinical and radiographic findings, immunohistochemical evaluation with a panel of D2-40, EMA, brachyury, and GFAP is most useful in distinguishing chordoid meningioma from chordoid glioma, skeletal myxoid chondrosarcoma, extraskeletal myxoid chondrosarcoma, chordoma, low-grade chondrosarcoma, and enchondroma.
  • Of note, this study is the first to characterize the D2-40 immunoprofile in extraskeletal myxoid chondrosarcoma, results that could be of utility in differential diagnostic assessment.
  • [MeSH-minor] Adolescent. Adult. Aged. Antibodies, Monoclonal. Antibodies, Monoclonal, Murine-Derived. Child. Chondroma / chemistry. Chondroma / pathology. Chondrosarcoma / chemistry. Chondrosarcoma / pathology. Diagnosis, Differential. Female. Fetal Proteins / analysis. Glial Fibrillary Acidic Protein / analysis. Glioma / chemistry. Glioma / pathology. Humans. Keratins / analysis. Male. Middle Aged. Mucin-1 / analysis. Predictive Value of Tests. S100 Proteins / analysis. T-Box Domain Proteins / analysis. Young Adult

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19194275.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Grant] United States / NLM NIH HHS / LM / T15 LM007033
  • [Publication-type] Comparative Study; Journal Article; Meta-Analysis
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Biomarkers, Tumor; 0 / Brachyury protein; 0 / Fetal Proteins; 0 / Glial Fibrillary Acidic Protein; 0 / Mucin-1; 0 / S100 Proteins; 0 / T-Box Domain Proteins; 0 / monoclonal antibody D2-40; 68238-35-7 / Keratins
  • [Other-IDs] NLM/ NIHMS775584; NLM/ PMC4847145
  •  go-up   go-down


7. Mavrogenis AF, Patapis P, Papaparaskeva KT, Galanis EC, Papagelopoulos PJ: Extraskeletal myxoid chondrosarcoma of the perineum. Orthopedics; 2009 Mar;32(3):216
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal myxoid chondrosarcoma of the perineum.
  • Extraskeletal myxoid chondrosarcoma is an aggressive tumor with significant metastatic potential.
  • A computed tomography-guided core needle biopsy was consistent with low-grade extraskeletal myxoid chondrosarcoma.
  • Histological analysis of the excised specimens was consistent with extraskeletal myxoid chondrosarcoma metastases.
  • Extraskeletal myxoid chondrosarcoma is an unusual soft tissue sarcoma with ultrastructural and molecular features distinct from that of skeletal myxoid chondrosarcoma.
  • The EWS-CHN gene fusion is highly specific to extraskeletal myxoid chondrosarcoma; the gene fusion is positive in >or=75% of cases.
  • Because of the prolonged survival of patients with extraskeletal myxoid chondrosarcoma, long-term follow-up is recommended for early detection of local recurrence or distant metastases.
  • [MeSH-major] Chondrosarcoma / secondary. Perineum / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Disease-Free Survival. Humans. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Lymph Nodes / pathology. Lymphatic Metastasis. Magnetic Resonance Imaging. Male. Radiography, Thoracic. Thoracotomy. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19309044.001).
  • [ISSN] 1938-2367
  • [Journal-full-title] Orthopedics
  • [ISO-abbreviation] Orthopedics
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


8. Tateishi U, Hasegawa T, Nojima T, Takegami T, Arai Y: MRI features of extraskeletal myxoid chondrosarcoma. Skeletal Radiol; 2006 Jan;35(1):27-33
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MRI features of extraskeletal myxoid chondrosarcoma.
  • OBJECTIVE: To describe the MRI features of extraskeletal myxoid chondrosarcoma in comparison with clinicopathologic findings.
  • CONCLUSION: Extraskeletal myxoid chondrosarcoma is an uncommon soft-tissue malignancy that may be recognized by MRI features of multi-lobular soft-tissue mass often invading extracompartmental, bony, and vascular structures.
  • [MeSH-major] Chondrosarcoma / pathology. Magnetic Resonance Imaging / methods. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Bone Neoplasms / pathology. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16220270.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


9. Ehara S, Nishida J, Shiraishi H, Yoshioka H, Okada K, Sumiya H, Takano H: Skeletal recurrences and metastases of extraskeletal myxoid chondrosarcoma. Skeletal Radiol; 2007 Sep;36(9):823-7
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Skeletal recurrences and metastases of extraskeletal myxoid chondrosarcoma.
  • OBJECTIVE: The objective was to elucidate clinical and imaging features of skeletal involvement, recurrences, and metastases of extraskeletal myxoid chondrosarcoma.
  • CONCLUSION: Although skeletal metastases of chondrosarcoma of bone and soft tissue are rare, myxoid chondrosarcomas, currently classified tumors of uncertain differentiation, rarely metastasize and/or recur in the bones.
  • [MeSH-major] Bone Neoplasms / secondary. Chondrosarcoma / pathology. Chondrosarcoma / secondary. Lung Neoplasms / secondary. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Multicenter Studies as Topic. Neoplasm Metastasis. Recurrence. Retrospective Studies

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17437101.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


10. Gupta R, Sharma MC, Attri S, Guleria S: Testicular metastasis of extraskeletal myxoid chondrosarcoma: report of first case. Urology; 2008 May;71(5):984.e1-4
MedlinePlus Health Information. consumer health - Testicular Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Testicular metastasis of extraskeletal myxoid chondrosarcoma: report of first case.
  • Metastasis from extraskeletal myxoid chondrosarcoma to the testis has not been previously reported.
  • We report a case of extraskeletal myxoid chondrosarcoma that, 4 years after surgery, manifested with testicular enlargement, a period punctuated by three local recurrences.
  • The testicular tumor showed pathologic features similar to the previous specimens, and metastatic myxoid chondrosarcoma was diagnosed.
  • To the best of our knowledge, this is the first case of extraskeletal myxoid chondrosarcoma with metastasis to the testis.
  • [MeSH-major] Chondrosarcoma / secondary. Soft Tissue Neoplasms / pathology. Testicular Neoplasms / secondary
  • [MeSH-minor] Adult. Humans. Male

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18308379.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. O'Brien J, Thornton J, Cawley D, Farrell M, Keohane K, Kaar G, McEvoy L, O'Brien DF: Extraskeletal myxoid chondrosarcoma of the cerebellopontine angle presenting during pregnancy. Br J Neurosurg; 2008 Jun;22(3):429-32
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal myxoid chondrosarcoma of the cerebellopontine angle presenting during pregnancy.
  • Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft-tissue sarcoma, which usually occurs in the lower extremities.
  • The clinical, radiological and pathological findings in extraskeletal myxoid chondrosarcoma, with an origin in the cerebellopontine angle, are described along with the issues associated with management of this tumour presenting acutely in a 26-year-old woman who was 20 weeks pregnant.
  • [MeSH-major] Cerebellar Neoplasms / pathology. Cerebellopontine Angle / pathology. Chondrosarcoma / pathology. Pregnancy Complications, Neoplastic / pathology. Sarcoma / pathology
  • [MeSH-minor] Adult. Female. Humans. Pregnancy. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18568733.001).
  • [ISSN] 0268-8697
  • [Journal-full-title] British journal of neurosurgery
  • [ISO-abbreviation] Br J Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


12. Ceylan K, Kizilkaya Z, Yavanoglu A: Extraskeletal myxoid chondrosarcoma of the nasal cavity. Eur Arch Otorhinolaryngol; 2006 Nov;263(11):1044-7
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal myxoid chondrosarcoma of the nasal cavity.
  • Extraskeletal myxoid chondrosarcoma presenting in the head and neck is extremely rare.
  • The tumour has a better prognosis than myxoid chondrosarcoma of the bone but surgical resection may be difficult due to its gelatinous nature.
  • We present a case of extraskeletal myxoid chondrosarcoma originating in the left nasal cavity of a 35-year-old woman.
  • [MeSH-major] Chondrosarcoma / diagnosis. Nasal Cavity. Nose Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16816935.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


13. Anderson JT, Lucas GL: Extraskeletal mesenchymal chondrosarcoma of the forearm: a case report. J Hand Surg Am; 2007 Mar;32(3):389-92
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal mesenchymal chondrosarcoma of the forearm: a case report.
  • Of the extraskeletal locations, the meninges, brain, and thigh are the most common.
  • This case report describes an extraskeletal mesenchymal chondrosarcoma involving the forearm.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / surgery. Soft Tissue Neoplasms / microbiology. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adult. Combined Modality Therapy. Female. Forearm. Humans. Magnetic Resonance Imaging. Radiotherapy Dosage

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17336849.001).
  • [ISSN] 0363-5023
  • [Journal-full-title] The Journal of hand surgery
  • [ISO-abbreviation] J Hand Surg Am
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Hashimoto N, Ueda T, Joyama S, Araki N, Beppu Y, Tatezaki S, Matsumoto S, Nakanishi K, Tomita Y, Yoshikawa H: Extraskeletal mesenchymal chondrosarcoma: an imaging review of ten new patients. Skeletal Radiol; 2005 Dec;34(12):785-92
Genetic Alliance. consumer health - TEN.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal mesenchymal chondrosarcoma: an imaging review of ten new patients.
  • OBJECTIVE: Extraskeletal mesenchymal chondrosarcoma (EMC) is a rare soft-tissue tumor that most arises in young adults.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Chondrosarcoma, Mesenchymal / radiography. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / radiography
  • [MeSH-minor] Adult. Aged. Female. Forearm. Humans. Japan. Leg. Magnetic Resonance Imaging. Male. Retrospective Studies. Thigh. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16211384.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Germany
  •  go-up   go-down


15. Okamoto Y, Minami M, Ueda T, Inadome Y, Tatsumura M, Sakane M: Extraskeletal mesenchymal chondrosarcoma of the cervical meninx. Radiat Med; 2007 Aug 1;25(7):355-8
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal mesenchymal chondrosarcoma of the cervical meninx.
  • We report a case of recurrent mesenchymal chondrosarcoma in the cervical paravertebral region that was diagnosed preoperatively by imaging studies.
  • This discrepancy between CT and MRI was well correlated with pathological findings of mesenchymal chondrosarcoma and suggested this entity.
  • [MeSH-major] Cervical Vertebrae. Chondrosarcoma, Mesenchymal / diagnosis. Spinal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Contrast Media. Diagnosis, Differential. Gadolinium DTPA. Humans. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17705006.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


16. Subramanian S, West RB, Marinelli RJ, Nielsen TO, Rubin BP, Goldblum JR, Patel RM, Zhu S, Montgomery K, Ng TL, Corless CL, Heinrich MC, van de Rijn M: The gene expression profile of extraskeletal myxoid chondrosarcoma. J Pathol; 2005 Aug;206(4):433-44
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The gene expression profile of extraskeletal myxoid chondrosarcoma.
  • Extraskeletal myxoid chondrosarcoma (EMC) is a soft tissue tumour that occurs primarily in the extremities and is characterized by a balanced translocation most commonly involving t(9;22) (q22;q12).
  • [MeSH-major] Chondrosarcoma / genetics. Gene Expression Regulation, Neoplastic / genetics. Soft Tissue Neoplasms / genetics
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Cell Differentiation / genetics. Cell Division / genetics. Cluster Analysis. DNA, Neoplasm / genetics. Female. Humans. In Situ Hybridization / methods. Male. Microtubules / genetics. Middle Aged. Neoplasm Proteins / analysis. Neurokinin B / analogs & derivatives. Neurokinin B / analysis. Oligonucleotide Array Sequence Analysis / methods. Oncogenes / genetics. Proto-Oncogene Proteins c-kit / genetics. Signal Transduction / genetics

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Pathological Society of Great Britain and Ireland
  • (PMID = 15920699.001).
  • [ISSN] 0022-3417
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA85129
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA, Neoplasm; 0 / Neoplasm Proteins; 86933-75-7 / Neurokinin B; 87096-84-2 / neuromedin B; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


17. Saito Y, Takemura S, Sakurada K, Sato S, Kayama T: [Intracranial extraskeletal mesenchymal chondrosarcoma arising from falx: a case report and literature review]. No Shinkei Geka; 2010 May;38(5):441-8
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial extraskeletal mesenchymal chondrosarcoma arising from falx: a case report and literature review].
  • Intracranial extraskeletal mesenchymal chondrosarcoma is a very rare tumor that affects young adults.
  • We report a 31-year-old woman with a huge intracranial extraskeletal mesenchymal chondrosarcoma.
  • Pathologic examination revealed a mesenchymal chondrosarcoma.
  • We review previously reported cases of extraskeletal intracranial mesenchymal chondrosarcoma and discuss imaging diagnosis, treatment strategies, and outcome.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / surgery. Chondrosarcoma, Mesenchymal / diagnosis. Chondrosarcoma, Mesenchymal / surgery. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / surgery
  • [MeSH-minor] Adult. Dura Mater. Female. Humans. Magnetic Resonance Imaging

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20522915.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 25
  •  go-up   go-down


18. Kumar R, Rekhi B, Shirazi N, Pais A, Amare P, Gawde D, Jambhekar N: Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case. Diagn Cytopathol; 2008 Dec;36(12):868-75
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
  • Extraskeletal myxoid chondrosarcoma (EMC) is an uncommon soft tissue sarcoma with evolving literature on its cytomorphological features and limited documentation of its molecular analysis.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma / pathology. Chromosomes, Human, Pair 22 / genetics. Chromosomes, Human, Pair 9 / genetics. RNA-Binding Protein EWS / genetics. Translocation, Genetic
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18925568.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA-Binding Protein EWS
  • [Number-of-references] 29
  •  go-up   go-down


19. Maheshwari AV, Jain AK, Dhammi IK: Extraskeletal paraarticular osteochondroma of the knee--a case report and tumor overview. Knee; 2006 Oct;13(5):411-4
Genetic Alliance. consumer health - Osteochondroma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal paraarticular osteochondroma of the knee--a case report and tumor overview.
  • Extraskeletal paraarticular osteochondromas are rather unusual osteocartilaginous lesions that arise in the soft tissues adjacent to the joint with no bony or joint continuity.
  • This diagnosis should be considered with the demonstration of a well-circumscribed extraskeletal mineralized mass without any direct continuity with adjacent bone or joint.
  • Differentiation from other lesions, particularly synovial osteochondromatosis and chondrosarcoma is essential to avoid unnecessary aggressive surgical procedures as marginal excision is adequate for these lesions.
  • [MeSH-minor] Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16837200.001).
  • [ISSN] 0968-0160
  • [Journal-full-title] The Knee
  • [ISO-abbreviation] Knee
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


20. Noguchi H, Mitsuhashi T, Seki K, Tochigi N, Tsuji M, Shimoda T, Hasegawa T: Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes. Hum Pathol; 2010 Mar;41(3):336-42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
  • Extraskeletal myxoid chondrosarcomas (EMCs) are characterized histologically by a cord-like or lace-like arrangement of small round cells or short spindle cells with eosinophilic cytoplasm distributed in a rich myxoid matrix.
  • [MeSH-major] Calmodulin-Binding Proteins / genetics. Chondrosarcoma / genetics. DNA-Binding Proteins / genetics. RNA-Binding Proteins / genetics. Receptors, Steroid / genetics. Receptors, Thyroid Hormone / genetics. Soft Tissue Neoplasms / genetics
  • [MeSH-minor] Adult. Aged. Female. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Neoplasm Proteins / genetics. Oncogene Fusion / genetics. Oncogene Proteins, Fusion / genetics. Reverse Transcriptase Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 19775727.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calmodulin-Binding Proteins; 0 / DNA-Binding Proteins; 0 / EWSR1 protein, human; 0 / NR4A3 protein, human; 0 / Neoplasm Proteins; 0 / Oncogene Proteins, Fusion; 0 / RNA-Binding Proteins; 0 / Receptors, Steroid; 0 / Receptors, Thyroid Hormone
  •  go-up   go-down


21. Bu X, Dai X: Primary mesenchymal chondrosarcoma of the pancreas. Ann R Coll Surg Engl; 2010 Apr;92(3):W10-2
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary mesenchymal chondrosarcoma of the pancreas.
  • Extraskeletal chondrosarcomas are rare and there is only one reported case of primary pancreatic chondrosarcoma.
  • The mass was completely excised, and the histopathological diagnosis was primary mesenchymal pancreatic chondrosarcoma.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Neoplasm Recurrence, Local / radiography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20412660.001).
  • [ISSN] 1478-7083
  • [Journal-full-title] Annals of the Royal College of Surgeons of England
  • [ISO-abbreviation] Ann R Coll Surg Engl
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


22. Tsuchiya T, Osanai T, Ogose A, Tamura G, Chano T, Kaneko Y, Ishikawa A, Orui H, Wada T, Ikeda T, Namba M, Takigawa M, Kawashima H, Hotta T, Tsuchiya A, Ogino T, Motoyama T: Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma. Cancer Genet Cytogenet; 2005 Apr 15;158(2):148-55
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
  • Germline mutation and functional loss of EXT1 or EXT2 are commonly found in multiple osteochondromas and predispose to the development of chondrosarcoma.
  • To evaluate promoter methylation (which is an epigenetic gene silencing mechanism) of EXT1 and EXT2, we performed methylation-specific polymerase chain reaction (PCR) for 20 chondrosarcoma cases (12 primary, 3 secondary to osteochondroma, 2 secondary to enchondromatosis, 2 extraskeletal ordinary, and 1 clear cell) and in five cell lines.
  • In addition, mutation analysis of the EXT1 and EXT2 coding regions was performed using PCR-single-strand conformation polymorphism and sequencing analysis for 12 of the 20 chondrosarcoma cases (8 primary, 1 secondary to enchondromatosis, 1 secondary to osteochondroma, and 2 extraskeletal ordinary) and five cell lines.
  • Two missense mutations in EXT2 (D227E and R299H) were detected among the chondrosarcoma cases.
  • When considering tumor development in primary chondrosarcoma, we should include mutations in EXT2, along with the status of other members of the EXT gene family.
  • [MeSH-major] Chondrosarcoma / genetics. DNA Methylation. Mutation, Missense. N-Acetylglucosaminyltransferases / genetics. Promoter Regions, Genetic
  • [MeSH-minor] 5' Untranslated Regions. Adolescent. Adult. Aged. Base Sequence. CpG Islands. DNA Mutational Analysis. Female. Germ-Line Mutation. Humans. Loss of Heterozygosity. Male. Middle Aged. Molecular Sequence Data. Reverse Transcriptase Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15796962.001).
  • [ISSN] 0165-4608
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 5' Untranslated Regions; EC 2.4.1.- / N-Acetylglucosaminyltransferases; EC 2.4.1.224 / exostosin-1; EC 2.4.1.224 / exostosin-2
  •  go-up   go-down


23. Bonavolonta P, Strianese D, Maria Luisa Vecchione MM, Staibano S: A challenging case of primary orbital mesenchymal chondrosarcoma. Orbit; 2010 Oct;29(5):281-3
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A challenging case of primary orbital mesenchymal chondrosarcoma.
  • Mesenchymal chondrosarcoma is an uncommon lesion of the bone and extraskeletal tissue involving very rarely the orbit.
  • We present a case of a 23-year-old man with primary orbital mesenchymal chondrosarcoma (OMC) with an uncommon management.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Humans. Magnetic Resonance Imaging. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20572753.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


24. Kaur A, Kishore P, Agrawal A, Gupta A: Mesenchymal chondrosarcoma of the orbit: a report of two cases and review of the literature. Orbit; 2008;27(1):63-7
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of the orbit: a report of two cases and review of the literature.
  • Mesenchymal chondrosarcoma, an uncommon lesion in bone and extraskeletal tissue, is extremely rare in the orbit.
  • Two cases of orbital mesenchymal chondrosarcoma in young adults presenting with proptosis and diminution of vision are reported.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Neoplasm Recurrence, Local / therapy. Orbital Neoplasms / pathology
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Cyclophosphamide / administration & dosage. Dactinomycin / administration & dosage. Female. Humans. Male. Orbit Evisceration. Radiotherapy, Adjuvant. Reoperation. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. DACTINOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18307151.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 1CC1JFE158 / Dactinomycin; 5J49Q6B70F / Vincristine; 8N3DW7272P / Cyclophosphamide; VAC protocol
  • [Number-of-references] 11
  •  go-up   go-down


25. Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Rushing EJ: Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Hum Pathol; 2010 May;41(5):653-62
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
  • Mesenchymal chondrosarcoma, a rare malignant round cell and hyaline cartilage tumor, is most commonly intraosseous but can occur in extraskeletal sites.
  • We intensively observed the morphology and applied Sox9 (master regulator of chondrogenesis), beta-catenin (involved in bone formation, thought to inhibit chondrogenesis in a Sox9-dependent manner), and osteocalcin (a marker for osteoblastic phenotype) to 22 central nervous system and musculoskeletal mesenchymal chondrosarcoma.
  • Cases of mesenchymal chondrosarcoma were retrieved and reviewed from our files.
  • Immunohistochemistry and follow-up were obtained on mesenchymal chondrosarcoma and tumor controls.
  • Small round cells of mesenchymal chondrosarcoma were negative for osteocalcin.
  • SOX9 was positive in both components of 21 of 22 cases of mesenchymal chondrosarcoma. beta-Catenin highlighted rare nuclei at the interface between round cells and hyaline cartilage in 35% cases.
  • Mesenchymal chondrosarcoma demonstrates centrally located hyaline cartilage with a linear progression of chondrocytes from resting to proliferative to hypertrophic, which undergoes endochondral ossification, recapitulating growth plate cartilage and suggesting that this component of mesenchymal chondrosarcoma may be a differentiated (benign or metaplastic) component of a malignant metastasizing tumor.
  • This hyaline cartilage component is morphologically different from cartilage of control chondrosarcoma.
  • Mesenchymal chondrosarcoma can be separated from small cell osteosarcoma, using Sox 9 for cartilage and osteocalcin for osteoblastic phenotype.
  • Rare nuclear beta-catenin expression at the interface between hyaline cartilage and small round cells potentially implicates the APC/Wnt pathway during endochondral ossification in morphologically benign hyaline cartilage component of mesenchymal chondrosarcoma.
  • [MeSH-major] Bone Neoplasms / pathology. Bone and Bones / pathology. Brain Neoplasms / pathology. Chondrosarcoma, Mesenchymal / pathology. Hyaline Cartilage / pathology. Osteocalcin / metabolism. SOX9 Transcription Factor / metabolism. beta Catenin / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Chondrocytes / metabolism. Chondrocytes / pathology. Female. Humans. Immunohistochemistry. Male. Middle Aged. Ossification, Heterotopic / metabolism. Ossification, Heterotopic / pathology. Osteoblasts / metabolism. Osteoblasts / pathology

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Inc.
  • (PMID = 20138330.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / SOX9 Transcription Factor; 0 / SOX9 protein, human; 0 / beta Catenin; 104982-03-8 / Osteocalcin
  •  go-up   go-down


26. Veras E, Abadeer R, Khurana H, Tan D, Ayala A: Solitary synovial osteochondroma. Ann Diagn Pathol; 2010 Apr;14(2):94-9
Genetic Alliance. consumer health - Osteochondroma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Solitary synovial osteochondroma (SSO) is a rare variant of extraskeletal osteochondroma.
  • Microscopically, lobulated adult-type hyaline cartilage with central calcification was noted.
  • Two cases were suggestive of chondrosarcoma on imaging studies.
  • In conclusion, SSO is a rare lesion that may mimic low-grade chondrosarcoma at times.
  • [MeSH-minor] Adult. Chondrosarcoma / pathology. Diagnosis, Differential. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20227014.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Wong NL, DI F: [Fine needle aspiration cytology of myxoid lesions of soft tissues: a study of 24 cases]. Zhonghua Bing Li Xue Za Zhi; 2007 Sep;36(9):619-23

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myxoid liposarcoma, extraskeletal myxoid chondrosarcoma and myxofibrosarcoma were the most common myxoid sarcomas.
  • [MeSH-minor] Adolescent. Adult. Aged. Bone Neoplasms / pathology. Bone Neoplasms / surgery. Chondrosarcoma / pathology. Chondrosarcoma / surgery. Diagnosis, Differential. Fasciitis / pathology. Fasciitis / surgery. Female. Humans. Male. Middle Aged. Myxoma / pathology. Myxoma / surgery. Prognosis. Sarcoma / pathology. Sarcoma / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18070452.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


28. Powers JW, Teitell M, Milisavljevic V: Congenital high-grade sarcoma presenting as skin nodules and respiratory distress in a neonate. J Perinatol; 2008 Feb;28(2):160-2
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report, to our knowledge, the first case of a congenital, widespread, aggressive high-grade sarcoma, presented as multiple skin nodules and respiratory distress in a neonate that had a t(9;22)(q22;q11-12) cytogenetic abnormality suggestive of a more indolent extraskeletal myxoid chondrosarcoma (EMC).
  • [MeSH-major] Chondrosarcoma / congenital. Chondrosarcoma / diagnosis. Respiratory Insufficiency / etiology. Skin Neoplasms / congenital. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Fatal Outcome. Female. Humans. Infant, Newborn. Male

  • MedlinePlus Health Information. consumer health - Respiratory Failure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18235511.001).
  • [ISSN] 0743-8346
  • [Journal-full-title] Journal of perinatology : official journal of the California Perinatal Association
  • [ISO-abbreviation] J Perinatol
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA107300; United States / NCI NIH HHS / CA / CA90571; United States / NICHD NIH HHS / HD / K12HD034610-11
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


29. Bulycheva IV, Makhson AN, Kuz'min IV, Denisov KA: [Soft tissue chondroma]. Arkh Patol; 2009 Mar-Apr;71(2):20-4
Genetic Alliance. consumer health - Chondroma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Differential diagnosis was made between synovial chondromatosis and chondrosarcoma.
  • The problems in the morphological diagnosis of extraskeletal chondroma are discussed in detail.
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Female. Humans. Middle Aged. Muscle, Skeletal / pathology. Shoulder

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19507573.001).
  • [ISSN] 0004-1955
  • [Journal-full-title] Arkhiv patologii
  • [ISO-abbreviation] Arkh. Patol.
  • [Language] rus
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


30. Sigauke E, Rakheja D, Maddox DL, Hladik CL, White CL, Timmons CF, Raisanen J: Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol; 2006 May;19(5):717-25
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In total, 12 brain, three renal and two soft tissue rhabdoid tumors were examined along with four glioblastomas, four pilocytic astrocytomas, four oligodendrogliomas, two ependymomas, two choroid plexus papillomas, five pituitary adenomas, four germinomas, four renal carcinomas with Xp11.2 translocations, two clear cell sarcomas, two Wilms' tumors, one renal medullary carcinoma, two desmoplastic small round cell tumors, two alveolar rhabdomyosarcomas, two embryonal rhabdomyosarcomas, one low-grade chondrosarcoma, two extraskeletal myxoid chondrosarcomas, one mesenchymal chondrosarcoma, four malignant peripheral nerve sheath tumors, five metastatic carcinomas and four epithelioid sarcomas, two primary and two metastatic.
  • [MeSH-minor] Adolescent. Adult. Brain Neoplasms / metabolism. Brain Neoplasms / pathology. Child. Child, Preschool. Chromosomal Proteins, Non-Histone. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Infant. Infant, Newborn. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16528370.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromosomal Proteins, Non-Histone; 0 / DNA-Binding Proteins; 0 / SMARCB1 protein, human; 0 / Transcription Factors
  •  go-up   go-down


31. Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S, Brennan MF: Why do patients with low-grade soft tissue sarcoma die? Ann Surg Oncol; 2008 Dec;15(12):3550-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Conversely, of DODR, extremity (47%) and trunk (18%) were the most common sites, but histology was more variable [liposarcoma 35%, malignant fibrous histiocytoma (MFH) 20%, fibrosarcoma 12%, extraskeletal myxoid chondrosarcoma 10%].

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1988 Jul 1;62(1):184-93 [3383114.001]
  • [Cites] Biometrics. 1978 Dec;34(4):541-54 [373811.001]
  • [Cites] Cancer. 1984 Feb 1;53(3):530-41 [6692258.001]
  • [Cites] Int J Cancer. 1984 Jan 15;33(1):37-42 [6693192.001]
  • [Cites] J Clin Oncol. 1983 Nov;1(11):710-9 [6668489.001]
  • [Cites] World J Surg. 1988 Jun;12(3):326-31 [3400243.001]
  • [Cites] J Clin Oncol. 1992 Aug;10(8):1317-29 [1634922.001]
  • [Cites] Arch Surg. 1993 Dec;128(12):1336-43 [8250705.001]
  • [Cites] Ann Surg. 1994 Feb;219(2):165-73 [8129487.001]
  • [Cites] J Clin Oncol. 1996 Mar;14(3):869-77 [8622035.001]
  • [Cites] Cancer. 1996 May 1;77(9):1823-30 [8646680.001]
  • [Cites] J Clin Oncol. 1996 May;14(5):1679-89 [8622088.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):350-62 [8996162.001]
  • [Cites] J Surg Oncol. 1999 Oct;72(2):77-82 [10518103.001]
  • [Cites] Cancer. 2005 Jan 15;103(2):402-8 [15578681.001]
  • [Cites] Immunol Res. 2005;32(1-3):231-45 [16106075.001]
  • [Cites] Histopathology. 2006 Jan;48(1):3-12 [16359532.001]
  • [Cites] Histopathology. 2006 Jan;48(1):42-50 [16359536.001]
  • [Cites] Cancer. 2001 May 15;91(10):1914-26 [11346874.001]
  • [Cites] J Clin Oncol. 2002 Feb 1;20(3):791-6 [11821462.001]
  • [Cites] Ann Surg. 2002 Mar;235(3):424-34 [11882765.001]
  • [Cites] Nat Immunol. 2002 Nov;3(11):991-8 [12407406.001]
  • [Cites] Cancer. 2003 May 15;97(10):2530-43 [12733153.001]
  • [Cites] Ann Surg Oncol. 2003 May;10(4):432-40 [12734093.001]
  • [Cites] Ann Surg Oncol. 2004 Jan;11(1):78-84 [14699038.001]
  • [Cites] Biometrics. 1979 Mar;35(1):25-39 [497336.001]
  • (PMID = 18830667.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA047179-09; United States / NCI NIH HHS / CA / P01 CA047179; United States / NCI NIH HHS / CA / P01 CA 047179; United States / NCI NIH HHS / CA / P01 CA047179-09
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS75337; NLM/ PMC2605207
  •  go-up   go-down


32. Willems SM, Schrage YM, Baelde JJ, Briaire-de Bruijn I, Mohseny A, Sciot R, Bovée JV, Hogendoorn PC: Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition. Histopathology; 2008 Mar;52(4):465-74
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intramuscular myxoma contained similar amounts of the various glycosaminoglycans as grade I myxofibrosarcoma; grade III myxofibrosarcoma contained less hyaluronic acid and more heparan sulphate, whereas extraskeletal myxoid chondrosarcoma contained predominantly chondroitin-4 and -6 sulphates.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Albumins / chemistry. Albumins / genetics. Alcian Blue / chemistry. Blotting, Western. Coloring Agents / chemistry. Female. Glycosaminoglycans / chemistry. Glycosaminoglycans / classification. Humans. In Situ Hybridization. Male. Middle Aged. Neoplasm Staging. RNA, Messenger / metabolism. Retrospective Studies. Tissue Array Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18315599.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Albumins; 0 / Coloring Agents; 0 / Glycosaminoglycans; 0 / RNA, Messenger; P4448TJR7J / Alcian Blue
  •  go-up   go-down


33. Huang D, Sumegi J, Dal Cin P, Reith JD, Yasuda T, Nelson M, Muirhead D, Bridge JA: C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. Genes Chromosomes Cancer; 2010 Sep;49(9):810-8
SciCrunch. HGNC: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondroid lipoma, a rare benign adipose tissue tumor, may histologically resemble myxoid liposarcoma or extraskeletal myxoid chondrosarcoma, but is genetically distinct.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Wiley-Liss, Inc.
  • [Cites] Biochim Biophys Acta. 2001 May 28;1519(1-2):13-29 [11406267.001]
  • [Cites] Genes Chromosomes Cancer. 2009 Dec;48(12):1051-6 [19760602.001]
  • [Cites] Cancer Genet Cytogenet. 2003 Mar;141(2):164-8 [12606137.001]
  • [Cites] Mol Cell Biol. 2003 Sep;23(18):6597-608 [12944485.001]
  • [Cites] J Biol Chem. 2003 Oct 24;278(43):41977-87 [14565952.001]
  • [Cites] Nat Genet. 2004 Jan;36(1):40-5 [14702039.001]
  • [Cites] Virchows Arch. 2004 Feb;444(2):208-10 [14722764.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Apr 15;150(2):93-115 [15066317.001]
  • [Cites] Cancer Genet Cytogenet. 2004 May;151(1):87-9 [15120917.001]
  • [Cites] Am J Surg Pathol. 1993 Nov;17(11):1103-12 [8214255.001]
  • [Cites] Int J Cancer. 1994 Aug 15;58(4):503-5 [8056446.001]
  • [Cites] Genes Chromosomes Cancer. 1995 Mar;12(3):220-3 [7536462.001]
  • [Cites] Nat Genet. 1995 Aug;10(4):436-44 [7670494.001]
  • [Cites] Skeletal Radiol. 1996 Aug;25(6):592-5 [8865499.001]
  • [Cites] Am J Clin Pathol. 1998 Nov;110(5):660-70 [9802353.001]
  • [Cites] Mod Pathol. 1999 Jan;12(1):88-91 [9950168.001]
  • [Cites] Am J Pathol. 1999 Jul;155(1):61-6 [10393837.001]
  • [Cites] Am J Surg Pathol. 1999 Oct;23(10):1300-4 [10524534.001]
  • [Cites] Am J Hematol. 2005 May;79(1):43-5 [15849773.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Feb 10;340(2):476-81 [16375854.001]
  • [Cites] Lab Invest. 2006 Jun;86(6):547-56 [16607381.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Jul;47(7):558-64 [18383210.001]
  • [Cites] Cancer Genet Cytogenet. 2008 Jun;183(2):121-4 [18503832.001]
  • [Cites] J Orthop Sci. 2008 May;13(3):273-82 [18528664.001]
  • [Cites] Mod Pathol. 2008 Nov;21(11):1311-9 [18604193.001]
  • [Cites] Hum Pathol. 2009 Sep;40(9):1296-303 [19386349.001]
  • [Cites] Nat Genet. 2001 Jul;28(3):220-1 [11431691.001]
  • (PMID = 20607705.001).
  • [ISSN] 1098-2264
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA036727-24S59009; United States / NCI NIH HHS / CA / 5 P30 CA036727-2452; United States / NCI NIH HHS / CA / P30 CA036727-24S59009; United States / NCI NIH HHS / CA / U-10-CA98543-091
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MKL2 protein, human; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Transcription Factors
  • [Other-IDs] NLM/ NIHMS203810; NLM/ PMC2904421
  •  go-up   go-down


34. Bergmann M, Abdalla Y, Neubauer U, Schildhaus HU, Probst-Cousin S: Primary intradural chordoma: report on three cases and review of the literature. Clin Neuropathol; 2010 May-Jun;29(3):169-76
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myxoid extraskeletal chondrosarcoma was excluded by in-situ-hybridization of the EWS gene.
  • [MeSH-minor] Adult. Aged. Biopsy. Female. Humans. Magnetic Resonance Imaging. Male

  • Genetic Alliance. consumer health - Chordoma.
  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20423692.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  •  go-up   go-down


35. Moore LF, Kransdorf MJ, Buskirk SJ, O'Connor MI, Menke DM: Radiation-induced pseudotumor following therapy for soft tissue sarcoma. Skeletal Radiol; 2009 Jun;38(6):579-84
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary tumors were malignant fibrous histiocytoma (n = 13), leiomyosarcoma (n = 6), liposarcoma (n = 3), synovial sarcoma (n = 1), and extraskeletal chondrosarcoma (n = 1).
  • [MeSH-minor] Adult. Aged. Comorbidity. Female. Florida / epidemiology. Humans. Incidence. Male. Middle Aged. Retrospective Studies. Risk Assessment / methods. Risk Factors

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19221738.001).
  • [ISSN] 1432-2161
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


36. Liu J, Guo HX, Yuan L, He ZY: [Extraskeletal mesenchymal chondrosarcoma of nasal cavity: report of a case]. Zhonghua Bing Li Xue Za Zhi; 2009 Mar;38(3):204-5
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Extraskeletal mesenchymal chondrosarcoma of nasal cavity: report of a case].
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Nasal Cavity. Nose Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD / metabolism. Cell Adhesion Molecules / metabolism. Diagnosis, Differential. Hemangiopericytoma / pathology. Humans. Lymphoma / pathology. Male. Neuroectodermal Tumors, Primitive / pathology. Vimentin / metabolism. Young Adult

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19575863.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules; 0 / Vimentin
  •  go-up   go-down






Advertisement